KKR & Co. Inc. has announced that Timothy R. Barakett will join its Board of Directors starting March 13, 2025. With his addition, there will be ten independent directors among the fourteen total board members. Mr. Barakett is the Founder and CEO of TRB Advisors, a private investment firm, and previously founded A.
FS KKR Capital provides good dividend income and has the potential for price growth, currently trading at a small premium compared to its average P/NAV ratio over the past three years. I consider FS KKR Capital a strong buy because it could improve its balance sheet and reduce its non-accrual percentage. However, in the last quarter, FS KKR Capital did not earn enough to cover its regular dividend, as its non-accrual percentage rose slightly from the previous quarter.
According to Bloomberg News, a group made up of Warburg Pincus and KKR is in discussions to buy the German medical packaging company Gerresheimer AG, as reported by sources close to the situation.
Bryn Talkington, the Managing Partner at Requisite Capital Management, appears on CNBC's "Halftime Report" to discuss her reasons for purchasing certain stocks that have dropped significantly in value.
Before FSK released its Q4 report, I wrote a negative analysis, taking my 27% profits and advising investors to stay away from the stock. Although the share price has risen by 5% since then, the company's fundamentals have deteriorated, and Q4 results were disappointing. In this article, I will explain further why I still believe investors should reconsider investing in FSK stock.
Assura Group (LSE:AGR) informed investors that it is likely to accept a £1.6 billion takeover proposal from KKR and Stonepeak Partners. After turning down multiple earlier offers, the board of the UK healthcare property investor announced that the consortium has increased its bid to a possible cash offer of 49.4p per share.
On Monday, Assura, a British healthcare real estate investment trust, announced that it may think about a £1.61 billion ($2.08 billion) proposal from KKR and Stonepeak Partners. This comes after they turned down four earlier offers from a different group led by KKR.
In 2025, KKR's shares fell by more than 25%, but they are still 21% higher compared to last year because of good financial performance. KKR plans to issue mandatory convertible preferred shares to raise $1.5 billion, which will slightly dilute shareholders by around 1% to invest in Strategic Holdings. However, the ambitious growth goals of Strategic Holdings could make KKR's earnings more complicated and unpredictable, leading to worries for investors.
We have just put together a list of the 10 stocks most affected by trade threats. In this article, we will examine how KKR & Co. Inc. (NYSE:KKR) compares to the other stocks. On Tuesday, Wall Street's main indices dropped again as investors sold off shares to reduce risks from the current situation.
TOKYO--(BUSINESS WIRE)--KKR is set to sell Seiyu to Trial Holdings.